Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema

Alcami completes third sterile fill-finish line at Research Triangle Park, NC

Black Buffalo partners with Sanova to support regulatory strategy and scientific innovation

Neurocrine Biosciences reveals new chapter in R&D strategy

Nicox completes key data package for NCX 470 NDA submissions

Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II

Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon

Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic

Physiomics secures follow-on UK contract for Phase 2 study support

Ascletis reports positive US Phase I data for oral IL-17 inhibitor ASC50

Dimerix completes adult recruitment in ACTION3 Phase 3 DMX-200 trial

RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL

Vanda files FDA Biologics License Application for imsidolimab in generalized pustular psoriasis

Amferia raises EUR3.5m to advance antimicrobial wound-care platform

Sobi s Aspaveli marketing authorisation receives positive European regulatory opinion